RE-DEEM Dose Finding Study for Dabigatran Etexilate in Patients With Acute Coronary Syndrome

NCT00621855 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1878

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Disease

Interventions

DRUG: placebo
DRUG: dabigatran etexilate
DRUG: dabigatran etexilate
DRUG: dabigatran etexilate
DRUG: dabigatran etexilate

Sponsor

Boehringer Ingelheim

Collaborators

[object Object]